• Skip to main content
  • Skip to secondary menu
  • Skip to primary sidebar
  • Skip to secondary sidebar
  • Skip to footer

  • COVID-19
  • Opinion
  • Health IT
    • Behavioral Health
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Patient Engagement
    • Population Health Management
    • Revenue Cycle Management
    • Social Determinants of Health
  • Digital Health
    • Artificial Intelligence
    • Blockchain
    • Mobile Health
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • M&A
  • Value-based Care
    • Accountable Care (ACOs)
    • Medicare Advantage
  • Life Sciences
  • Research

Reltio Raises $22M to Fuel Healthcare Data Management Apps

by Fred Pennic 07/28/2016 Leave a Comment

Reltio Raises $22M to Fuel Healthcare Data-Driven Apps

Reltio, a Redwood Shores, CA-based creator of new “data-driven apps” delivered through a modern data management platform  has raised $22M in Series B funding led by New Enterprise Associates (NEA). The round also included participation from existing investors  Crosslink Capital and .406 Ventures bringing Reltio’s total venture funding to $32M to date. The company plans to utilize the recent to strengthen its footprint in modern data management through accelerated hiring of talented individuals across all groups, and continued expansion into global markets.

With the emergence of IDNs, ACOs, MCOs the approach to healthcare is evolving. The focus in on overall well being and quality of life than just one-time treatment. This requires a new patient-centric approach with a complete understanding of patient’s needs, behaviors, and preferences and focus on building long-term relationships. 

Reltio’s core product, Reltio Cloud provides healthcare and life sciences organizations with a modern data management platform that enables a complete understanding of your patients, physicians, and other partners across all clinics and facilities, with real-time visibility into relationships, healthcare metrics, and utilization trends by the site of care.

Reltio also delivers a complete view of information for managed markets teams so they can optimize their activities and achieve better outcomes. Highlights include:

– Complete payer hierarchies down to the plan level

– Detailed views of payers, channels, regions, and plans

– Insight into formulary, competitive products and tiers

– Cross correlation of product metrics and longitudinal stats

– Identification and management of Pharmacy Benefit Manager details and associated contracts

Reltio founder, Manish Sood co-authored the patent that revolutionized master data management, and his previous work has become foundational to practices routinely in use today. Cloud-based Reltio data-driven app are currently available for every function and use case within a life sciences organization, including Affiliation Management, HCP/HCO Data Management, Product Data Management, Plan and Payer Management, Clinical Trial Site Investigator Management and Key Account Management.

In just the first half of 2016, Reltio has added leading companies in healthcare & life sciences with the recent signing of three of the top ten global pharmaceutical organizations, and an alliance with IMS Health to power IMS Health’s flagship IMS One Platform.

Tagged With: Reltio

Get in-depth healthcare technology analysis and commentary delivered straight to your email weekly

Reader Interactions

Primary Sidebar

Subscribe to HIT Consultant

Latest insightful articles delivered straight to your inbox weekly.

Submit a Tip or Pitch

Most Popular

Survey: Clinician Burnout Is A Public Health Crisis Demanding Urgent Action

17 Execs Share How Health IT Can Address Clinician Burnout, Staffing, & Capacity

Q/A: Dr. Johnson Talks Racial Disparities in Breast Cancer Care

Q/A: Dr. Johnson Talks Racial Disparities in Breast Cancer Care

Northwell Health Extends Contract with Allscripts Sunrise Platform Through 2027

Northwell to Deploy Epic Enterprise EHR Platform Across System

Sanofi Cuts Price of Lantus Insulin by 78% & Caps Out of Pocket Costs at $35 for All Patients

Sanofi Cuts Price of Lantus Insulin by 78% & Caps Out of Pocket Costs at $35 for All Patients

Pfizer Acquires Seagen for $43B to Tackle Cancer

Pfizer Acquires Seagen for $43B to Tackle Cancer

5 Key Trends Driving Purchasing Decisions in Healthcare IT

5 Key Trends Driving Purchasing Decisions in Healthcare IT

Sanofi to Acquire Diabetes Therapy Maker Provention Bio for $2.9B

Sanofi to Acquire Diabetes Therapy Maker Provention Bio for $2.9B

Dr. Arti Masturzo

Q/A: Dr. Masturzo Talks Addressing Food Insecurity with Patients

Transcarent Acquires 98point6 AI-Powered Virtual Care Platform and Care Business

Transcarent Acquires 98point6 AI-Powered Virtual Care Platform and Care Business

Eli Lilly Cuts Insulin Prices by 70%, Caps Patient Costs at $35 Per Month

Eli Lilly Cuts Insulin Prices by 70%, Caps Patient Costs at $35 Per Month

Secondary Sidebar

Footer

Company

  • About Us
  • Advertise with Us
  • Reprints and Permissions
  • 2023 Editorial Calendar
  • Submit An Op-Ed
  • Contact
  • Subscribe

Editorial Coverage

  • Opinion
  • Health IT
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Population Health Management
    • Revenue Cycle Management
  • Digital Health
    • Artificial Intelligence
    • Blockchain Tech
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • Value-Based Care
    • Accountable Care
    • Medicare Advantage

Connect

Subscribe to HIT Consultant Media

Latest insightful articles delivered straight to your inbox weekly

Copyright © 2023. HIT Consultant Media. All Rights Reserved. Privacy Policy |